Hutch News

Hutch News

Stories tagged 'finasteride'

Finasteride can reduce prostate cancer risk long term

Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss

March 21, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch public health researcher Dr. Joe Unger used an innovative trial design to confirm finasteride, a drug used to treat enlarged prostate or hair loss in men, has a long-term protective effect against prostate cancer.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 2, 2016

Global Oncology wins NCI grant; 1100 Eastlake Building honored; Bish Paul pens essay in Science; Dr. Joseph Unger leads finasteride study.

View story >


Heavy drinking and prostate health don't mix

Kristal and colleagues find heavy, daily drinking increases risk of high-grade prostate cancer and renders preventive drug ineffective

July 13, 2009

While current research regarding the relationship between alcohol consumption and prostate cancer risk is inconclusive, a new study by Dr. Alan Kristal and colleagues at the Fred Hutchinson Cancer Research Center reports that daily, heavy drinking increases the risk of high-grade prostate cancer. The paper, which appears in online in the journal CANCER, also reports that such drinking renders preventive drug therapy with finasteride ineffective.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.